MEI Historical Balance Sheet

MEIP Stock

USD 2.87 0.10 3.61%

Trend analysis of MEI Pharma balance sheet accounts such as Total Stockholder Equity of 32.7 M provides information on MEI Pharma's total assets, liabilities, and equity, which is the actual value of MEI Pharma to its prevalent stockholders. By breaking down trends over time using MEI Pharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining MEI Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MEI Pharma is a good buy for the upcoming year.

MEI Pharma Inventory

1.21

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

About MEI Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of MEI Pharma at a specified time, usually calculated after every quarter, six months, or one year. MEI Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of MEI Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which MEI currently owns. An asset can also be divided into two categories, current and non-current.

MEI Pharma Balance Sheet Chart

At this time, MEI Pharma's Short and Long Term Debt Total is relatively stable compared to the past year. As of 01/20/2025, Property Plant And Equipment Gross is likely to grow to about 2.9 M, while Total Stockholder Equity is likely to drop slightly above 32.7 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of MEI Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MEI Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on MEI Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MEI Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from MEI Pharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into MEI Pharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.At this time, MEI Pharma's Short and Long Term Debt Total is relatively stable compared to the past year. As of 01/20/2025, Property Plant And Equipment Gross is likely to grow to about 2.9 M, while Total Stockholder Equity is likely to drop slightly above 32.7 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	11.0M	5.2M	6.0M	3.9M
Total Assets	120.8M	41.4M	47.6M	62.7M

Other Current Liab Total Assets

MEI Pharma balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Retained Earnings	Short Term Investments	Short Long Term Debt Total	Non Current Liabilities Total	Property Plant And Equipment Net	Non Current Assets Total	Property Plant And Equipment Gross	Property Plant Equipment	Net Tangible Assets	Good Will	Retained Earnings Total Equity	Capital Surpluse	Intangible Assets
Total Assets		0.73	0.92	0.65	0.22	0.71	0.09	1.0	0.46	0.7	0.52	0.96	1.0	-0.57	0.98	0.09	0.95	0.62	0.62	0.58	0.21	0.65	0.12	-0.65	0.66	0.12
Other Current Liab	0.73		0.84	0.32	0.48	0.87	-0.06	0.7	0.74	0.92	0.76	0.76	0.7	-0.86	0.7	0.48	0.72	0.85	0.85	0.88	0.62	0.29	0.13	-0.84	0.84	0.13
Total Current Liabilities	0.92	0.84		0.42	0.44	0.85	-0.08	0.9	0.63	0.77	0.62	0.95	0.9	-0.71	0.91	0.21	0.92	0.77	0.76	0.75	0.43	0.41	0.0	-0.78	0.76	0.0
Total Stockholder Equity	0.65	0.32	0.42		-0.2	0.2	0.18	0.68	0.15	0.18	0.31	0.42	0.68	-0.27	0.63	0.05	0.41	-0.03	-0.02	-0.06	-0.16	0.96	0.58	-0.3	0.44	0.58
Net Debt	0.22	0.48	0.44	-0.2		0.48	-0.86	0.19	0.59	0.38	0.51	0.31	0.2	-0.55	0.34	0.33	0.27	0.4	0.37	0.46	0.57	-0.19	-0.49	-0.6	0.51	-0.49
Accounts Payable	0.71	0.87	0.85	0.2	0.48		-0.08	0.69	0.68	0.77	0.67	0.77	0.68	-0.78	0.69	0.35	0.74	0.82	0.81	0.83	0.57	0.18	-0.01	-0.79	0.77	-0.01
Cash	0.09	-0.06	-0.08	0.18	-0.86	-0.08		0.1	-0.41	0.06	-0.34	0.07	0.08	0.29	-0.08	-0.28	0.1	0.12	0.15	0.04	-0.38	0.18	0.46	0.35	-0.28	0.46
Cash And Short Term Investments	1.0	0.7	0.9	0.68	0.19	0.69	0.1		0.44	0.66	0.5	0.95	1.0	-0.56	0.98	0.08	0.94	0.59	0.59	0.54	0.18	0.68	0.15	-0.63	0.65	0.15
Common Stock Shares Outstanding	0.46	0.74	0.63	0.15	0.59	0.68	-0.41	0.44		0.63	0.97	0.45	0.44	-0.95	0.52	0.8	0.4	0.5	0.49	0.63	0.93	0.18	0.11	-0.95	0.87	0.11
Other Current Assets	0.7	0.92	0.77	0.18	0.38	0.77	0.06	0.66	0.63		0.62	0.77	0.66	-0.74	0.65	0.37	0.75	0.87	0.86	0.88	0.53	0.18	-0.03	-0.71	0.69	-0.03
Other Stockholder Equity	0.52	0.76	0.62	0.31	0.51	0.67	-0.34	0.5	0.97	0.62		0.46	0.5	-0.96	0.57	0.85	0.41	0.47	0.45	0.58	0.86	0.34	0.27	-0.95	0.89	0.27
Total Liab	0.96	0.76	0.95	0.42	0.31	0.77	0.07	0.95	0.45	0.77	0.46		0.95	-0.56	0.93	0.03	1.0	0.75	0.75	0.71	0.26	0.42	-0.08	-0.63	0.62	-0.08
Total Current Assets	1.0	0.7	0.9	0.68	0.2	0.68	0.08	1.0	0.44	0.66	0.5	0.95		-0.55	0.98	0.07	0.94	0.57	0.57	0.53	0.18	0.68	0.13	-0.63	0.65	0.13
Retained Earnings	-0.57	-0.86	-0.71	-0.27	-0.55	-0.78	0.29	-0.56	-0.95	-0.74	-0.96	-0.56	-0.55		-0.6	-0.77	-0.52	-0.61	-0.6	-0.7	-0.84	-0.26	-0.18	0.98	-0.93	-0.18
Short Term Investments	0.98	0.7	0.91	0.63	0.34	0.69	-0.08	0.98	0.52	0.65	0.57	0.93	0.98	-0.6		0.13	0.92	0.56	0.56	0.54	0.27	0.65	0.06	-0.7	0.68	0.06
Short Long Term Debt Total	0.09	0.48	0.21	0.05	0.33	0.35	-0.28	0.08	0.8	0.37	0.85	0.03	0.07	-0.77	0.13		-0.01	0.21	0.2	0.36	0.81	0.11	0.35	-0.68	0.62	0.35
Non Current Liabilities Total	0.95	0.72	0.92	0.41	0.27	0.74	0.1	0.94	0.4	0.75	0.41	1.0	0.94	-0.52	0.92	-0.01		0.74	0.73	0.69	0.21	0.41	-0.1	-0.59	0.58	-0.1
Property Plant And Equipment Net	0.62	0.85	0.77	-0.03	0.4	0.82	0.12	0.59	0.5	0.87	0.47	0.75	0.57	-0.61	0.56	0.21	0.74		1.0	0.98	0.51	-0.01	-0.08	-0.6	0.54	-0.08
Non Current Assets Total	0.62	0.85	0.76	-0.02	0.37	0.81	0.15	0.59	0.49	0.86	0.45	0.75	0.57	-0.6	0.56	0.2	0.73	1.0		0.98	0.49	0.0	-0.05	-0.59	0.53	-0.05
Property Plant And Equipment Gross	0.58	0.88	0.75	-0.06	0.46	0.83	0.04	0.54	0.63	0.88	0.58	0.71	0.53	-0.7	0.54	0.36	0.69	0.98	0.98		0.65	-0.04	-0.06	-0.69	0.61	-0.06
Property Plant Equipment	0.21	0.62	0.43	-0.16	0.57	0.57	-0.38	0.18	0.93	0.53	0.86	0.26	0.18	-0.84	0.27	0.81	0.21	0.51	0.49	0.65		-0.13	0.03	-0.81	0.7	0.03
Net Tangible Assets	0.65	0.29	0.41	0.96	-0.19	0.18	0.18	0.68	0.18	0.18	0.34	0.42	0.68	-0.26	0.65	0.11	0.41	-0.01	0.0	-0.04	-0.13		0.61	-0.31	0.36	0.61
Good Will	0.12	0.13	0.0	0.58	-0.49	-0.01	0.46	0.15	0.11	-0.03	0.27	-0.08	0.13	-0.18	0.06	0.35	-0.1	-0.08	-0.05	-0.06	0.03	0.61		-0.12	0.19	1.0
Retained Earnings Total Equity	-0.65	-0.84	-0.78	-0.3	-0.6	-0.79	0.35	-0.63	-0.95	-0.71	-0.95	-0.63	-0.63	0.98	-0.7	-0.68	-0.59	-0.6	-0.59	-0.69	-0.81	-0.31	-0.12		-0.94	-0.12
Capital Surpluse	0.66	0.84	0.76	0.44	0.51	0.77	-0.28	0.65	0.87	0.69	0.89	0.62	0.65	-0.93	0.68	0.62	0.58	0.54	0.53	0.61	0.7	0.36	0.19	-0.94		0.19
Intangible Assets	0.12	0.13	0.0	0.58	-0.49	-0.01	0.46	0.15	0.11	-0.03	0.27	-0.08	0.13	-0.18	0.06	0.35	-0.1	-0.08	-0.05	-0.06	0.03	0.61	1.0	-0.12	0.19

Click cells to compare fundamentals

MEI Pharma Account Relationship Matchups

MEI Pharma balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	174.1M	177.8M	120.8M	41.4M	47.6M	62.7M
Other Current Liab	7.5M	9.9M	11.0M	5.2M	6.0M	3.9M
Total Current Liabilities	30.3M	24.4M	20.3M	8.4M	9.6M	8.3M
Total Stockholder Equity	41.4M	52.4M	24.6M	33.0M	38.0M	32.7M
Net Debt	(245K)	(6.1M)	(4.2M)	(3.7M)	(4.3M)	(4.5M)
Accounts Payable	6.4M	7.9M	6.1M	3.2M	3.6M	2.2M
Cash	8.5M	15.7M	16.9M	3.7M	3.3M	3.2M
Cash And Short Term Investments	153.4M	153.3M	100.7M	38.3M	44.1M	57.3M
Common Stock Shares Outstanding	5.7M	6.3M	6.7M	6.7M	7.7M	8.0M
Liabilities And Stockholders Equity	174.1M	177.8M	120.8M	41.4M	47.6M	62.7M
Other Current Assets	3.8M	7.7M	11.3M	2.4M	2.8M	1.9M
Other Stockholder Equity	369.2M	426.6M	430.6M	421.2M	484.4M	508.6M
Total Liab	132.7M	125.4M	96.2M	8.4M	9.6M	9.1M
Total Current Assets	164.8M	167.1M	107.5M	40.8M	46.9M	60.9M
Retained Earnings	(327.8M)	(374.2M)	(406.0M)	(388.2M)	(349.4M)	(331.9M)
Short Term Investments	144.9M	137.5M	83.8M	34.6M	39.8M	70.4M
Property Plant And Equipment Net	9.3M	10.7M	13.3M	606K	696.9K	662.1K
Non Current Assets Total	9.3M	10.7M	13.3M	606K	696.9K	662.1K
Property Plant And Equipment Gross	9.3M	11.4M	14.3M	2.4M	2.7M	2.9M
Property Plant Equipment	1.1M	9.3M	10.7M	13.3M	15.3M	16.0M
Net Tangible Assets	78.2M	41.4M	52.4M	24.6M	28.3M	48.6M
Non Currrent Assets Other	(1.1M)	(9.3M)	(10.7M)	(13.3M)	(12.0M)	(11.4M)
Current Deferred Revenue	14.8M	14.6M	4.8M	317K	364.6K	346.3K
Net Invested Capital	41.4M	52.4M	24.6M	33.0M	29.7M	37.9M
Net Working Capital	134.5M	142.7M	87.2M	32.4M	37.3M	35.4M
Other Liab	108.2M	95.1M	92.2M	64.5M	74.2M	78.2M
Net Receivables	20.4M	7.6M	10.0M	85K	76.5K	72.7K

Pair Trading with MEI Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against MEI Stock

0.45

MBFJF

Mitsubishi UFJ Financial

Pair Corr

The ability to find closely correlated positions to MEI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEI Pharma to buy it.

The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for MEI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEI Historical Balance Sheet

MEI Pharma Inventory

1.21

About MEI Balance Sheet Analysis

MEI Pharma Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

MEI Pharma balance sheet Correlations

MEI Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEI Pharma balance sheet Accounts

Pair Trading with MEI Pharma

Moving against MEI Stock

Additional Tools for MEI Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Liabilities Total	+ 1.0	Total Liab
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Intangible Assets	+ 1.0	Good Will

Retained Earnings	- 0.96	Other Stockholder Equity
Retained Earnings Total Equity	- 0.95	Other Stockholder Equity
Retained Earnings Total Equity	- 0.95	Common Stock Shares Outstanding
Retained Earnings	- 0.95	Common Stock Shares Outstanding
Capital Surpluse	- 0.94	Retained Earnings Total Equity
Capital Surpluse	- 0.93	Retained Earnings